James B. Tananbaum, Director at Vanda Pharmaceuticals Inc. (VNDA), sold 745,469 shares at $26.56 ($19.8M) on 2006-12-11, disclosed to the SEC on 2006-12-13.
Open-market sale of $19.8M VNDA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.56 | 11,079 | $294K | 1.5% |
| 2 | $26.56 | 727,512 | $19.3M | 97.6% |
| 3 | $25.27 | 103 | $3K | 0.0% |
| 4 | $25.27 | 6,775 | $171K | 0.9% |
| Total | $26.55 avg | 745,469 | $19.8M | 100% |
| Filing → |
| CRTX | SELL | 2007-06-08 | $1.6M | — | Filing → |
| CRTX | SELL | 2007-06-05 | $3.1M | — | Filing → |